Credit Suisse’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-13,514
| Closed | -$263K | – | 3169 |
|
|
2023
Q2 | $263K | Buy |
13,514
+557
| +4% | +$10.8K | ﹤0.01% | 3022 |
|
|
2023
Q1 | $368K | Buy |
12,957
+1,093
| +9% | +$31K | ﹤0.01% | 2894 |
|
|
2022
Q4 | $347K | Buy |
11,864
+3,203
| +37% | +$93.6K | ﹤0.01% | 2949 |
|
|
2022
Q3 | $229K | Buy |
8,661
+154
| +2% | +$4.07K | ﹤0.01% | 3179 |
|
|
2022
Q2 | $378K | Sell |
8,507
-357
| -4% | -$15.9K | ﹤0.01% | 3008 |
|
|
2022
Q1 | $439K | Buy |
8,864
+174
| +2% | +$8.62K | ﹤0.01% | 3031 |
|
|
2021
Q4 | $443K | Buy |
8,690
+101
| +1% | +$5.15K | ﹤0.01% | 3103 |
|
|
2021
Q3 | $480K | Sell |
8,589
-1,417
| -14% | -$79.2K | ﹤0.01% | 3015 |
|
|
2021
Q2 | $428K | Sell |
10,006
-131
| -1% | -$5.6K | ﹤0.01% | 3104 |
|
|
2021
Q1 | $424K | Sell |
10,137
-9,297
| -48% | -$389K | ﹤0.01% | 3034 |
|
|
2020
Q4 | $906K | Sell |
19,434
-5,421
| -22% | -$253K | ﹤0.01% | 2628 |
|
|
2020
Q3 | $1.06M | Sell |
24,855
-393,237
| -94% | -$16.7M | ﹤0.01% | 2226 |
|
|
2020
Q2 | $20.1M | Buy |
418,092
+13,149
| +3% | +$631K | 0.01% | 737 |
|
|
2020
Q1 | $18.6M | Buy |
404,943
+162,826
| +67% | +$7.49M | 0.02% | 696 |
|
|
2019
Q4 | $14.5M | Buy |
242,117
+7,557
| +3% | +$454K | 0.01% | 913 |
|
|
2019
Q3 | $13.3M | Buy |
234,560
+216,799
| +1,221% | +$12.3M | 0.01% | 870 |
|
|
2019
Q2 | $989K | Buy |
17,761
+9,812
| +123% | +$546K | ﹤0.01% | 2363 |
|
|
2019
Q1 | $401K | Buy |
7,949
+353
| +5% | +$17.8K | ﹤0.01% | 2893 |
|
|
2018
Q4 | $305K | Sell |
7,596
-6,646
| -47% | -$267K | ﹤0.01% | 2984 |
|
|
2018
Q3 | $987K | Buy |
14,242
+1,511
| +12% | +$105K | ﹤0.01% | 2436 |
|
|
2018
Q2 | $963K | Buy |
12,731
+3,603
| +39% | +$273K | ﹤0.01% | 2599 |
|
|
2018
Q1 | $481K | Sell |
9,128
-929
| -9% | -$49K | ﹤0.01% | 2970 |
|
|
2017
Q4 | $537K | Sell |
10,057
-4,184
| -29% | -$223K | ﹤0.01% | 2914 |
|
|
2017
Q3 | $850K | Sell |
14,241
-5,915
| -29% | -$353K | ﹤0.01% | 2760 |
|
|
2017
Q2 | $1.59M | Sell |
20,156
-9,686
| -32% | -$764K | ﹤0.01% | 2041 |
|
|
2017
Q1 | $2.48M | Sell |
29,842
-6,060
| -17% | -$503K | ﹤0.01% | 1891 |
|
|
2016
Q4 | $2.85M | Buy |
35,902
+887
| +3% | +$70.4K | ﹤0.01% | 1862 |
|
|
2016
Q3 | $2.45M | Sell |
35,015
-6,919
| -16% | -$485K | ﹤0.01% | 1958 |
|
|
2016
Q2 | $1.63M | Sell |
41,934
-21,531
| -34% | -$836K | ﹤0.01% | 2252 |
|
|
2016
Q1 | $2.57M | Buy |
63,465
+57,771
| +1,015% | +$2.34M | ﹤0.01% | 1803 |
|
|
2015
Q4 | $505K | Buy |
5,694
+2,206
| +63% | +$196K | ﹤0.01% | 3155 |
|
|
2015
Q3 | $259K | Sell |
3,488
-7,740
| -69% | -$575K | ﹤0.01% | 3584 |
|
|
2015
Q2 | $908K | Sell |
11,228
-3,149
| -22% | -$255K | ﹤0.01% | 3023 |
|
|
2015
Q1 | $602K | Buy |
+14,377
| New | +$602K | ﹤0.01% | 3156 |
|